A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This Phase 1 clinical study is a double-blind, randomized, placebo-controlled, parallel group study to assess the safety, tolerability, pharmacokinetics (PK), food effect, and drug interaction potential of ACHN-383 and ACHN-789 co-administered orally as separate capsules in healthy subjects
Epistemonikos ID: 46f13f4d672e16cd5e3f2308a90510ab27af5ad1
First added on: May 20, 2024